Opus Genetics (IRD) Cash from Operations Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | -41.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.51% |
| Dec 31, 2025 | -32.20% |
| Sep 30, 2025 | -20.02% |
| Jun 30, 2025 | -40.83% |
| Mar 31, 2025 | -57.35% |
| Dec 31, 2024 | -263.54% |
| Sep 30, 2024 | -70.83% |
| Jun 30, 2024 | -837.31% |
| Mar 31, 2024 | -56.77% |
| Dec 31, 2023 | -84.20% |
| Sep 30, 2023 | 33.24% |
| Jun 30, 2023 | 125.96% |
| Mar 31, 2023 | 40.91% |
| Dec 31, 2022 | 609.94% |
| Sep 30, 2022 | -25.50% |
| Jun 30, 2022 | 11.99% |
| Mar 31, 2022 | -6.16% |
| Dec 31, 2021 | -29.55% |
| Sep 30, 2021 | -239.39% |
| Jun 30, 2021 | -564.82% |
| Mar 31, 2021 | -693.99% |
| Dec 31, 2020 | -187.66% |
| Sep 30, 2020 | 55.59% |
| Jun 30, 2020 | 63.96% |
| Mar 31, 2020 | 83.29% |
| Dec 31, 2019 | 207.61% |
| Sep 30, 2019 | 42.93% |
| Jun 30, 2019 | 59.43% |
| Mar 31, 2019 | 21.76% |
| Dec 31, 2018 | -24.70% |
| Sep 30, 2018 | -20.88% |
| Jun 30, 2018 | -8.63% |
| Mar 31, 2018 | -34.29% |
| Dec 31, 2017 | -148.09% |
| Sep 30, 2017 | -10.44% |
| Jun 30, 2017 | 19.03% |
| Mar 31, 2017 | -17.44% |
| Dec 31, 2016 | 66.12% |
| Sep 30, 2016 | 30.67% |
| Jun 30, 2016 | -14.99% |
| Mar 31, 2016 | 12.11% |
| Dec 31, 2015 | -51.37% |
| Sep 30, 2015 | -73.06% |
| Jun 30, 2015 | -49.19% |
| Mar 31, 2015 | -56.75% |
| Dec 31, 2014 | -29.48% |
| Sep 30, 2014 | -54.79% |
| Jun 30, 2014 | -17.87% |
| Mar 31, 2014 | -66.07% |
| Dec 31, 2013 | -109.50% |
| Sep 30, 2013 | -1.88% |
| Jun 30, 2013 | -26.46% |
| Mar 31, 2013 | 19.04% |
| Dec 31, 2012 | 78.00% |
| Sep 30, 2012 | 47.81% |
| Jun 30, 2012 | 60.91% |
| Mar 31, 2012 | 21.00% |
| Dec 31, 2011 | -101.62% |
| Sep 30, 2011 | -98.90% |